GL1X · GenesisL1 explorer

Research workbench

HIV-1 rt with pyridone non-nucleoside inhibitor

Analyse HIV-1 rt with pyridone non-nucleoside inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3FFI
Type
protein
Length
952 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Reverse TRANSCRIPTASE/RIBONUCLEASE H; Rt P51
EC
2.7.7.49, 2.7.7.7, 3.1.26.4
UniProt
P04585
Ligands
3OB
Pockets
15 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 35% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AReverse TRANSCRIPTASE/RIBONUCLEASE H (EC 2.7.7.49, 2.7.7.7, 3.1.26.4)protein54932% helix, 22% strandP04585
BRt P51protein40338% helix, 18% strandP04585

Ligands and binding sites

  • 3OB · 3-chloro-5-({6-[2-(3,4-dihydroisoquinolin-2(1H)-yl)-2-oxoethyl]-3-(dimethylamino)-2-oxo-1,2-dihydropyridin-4-yl}oxy)benzonitrile · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17980.780.81733OB
24330.710.8238empty
32710.680.8339empty
42540.610.8029empty
53160.580.7740empty

Interfaces

1 interface between chains.

  • A–B · 2837 Ų buried · 36 hydrogen bonds · protein-protein

Compared structures

  • 3FFI · HIV-1 RT with pyridone non-nucleoside inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.